<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004818'>Paroxysmal nocturnal hemoglobinuria</z:hpo> is a clonal hematopoietic stem cell disease that manifests with intravascular <z:mp ids='MP_0010163'>hemolysis</z:mp>, <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo>, <z:mp ids='MP_0005048'>thrombosis</z:mp>, and smooth muscle <z:hpo ids='HP_0001332'>dystonias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The disease can arise de novo or in the setting of acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> patients to date have been shown to harbor PIG-A mutations; the product of this gene is required for the synthesis of <z:chebi fb="0" ids="24410">glycosylphosphatidylinositol</z:chebi> (GPI) anchored proteins </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> patients, PIG-A mutations arise from a multipotent hematopoietic stem cell </plain></SENT>
<SENT sid="4" pm="."><plain>Interestingly, PIG-A mutations can also be found in the peripheral blood of most healthy controls; however, these mutations arise from progenitor cells rather than multipotent hematopoietic stem cells and do not propagate the disease </plain></SENT>
<SENT sid="5" pm="."><plain>The mechanism of whereby <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> stem cells achieve clonal dominance remains unclear </plain></SENT>
<SENT sid="6" pm="."><plain>The leading hypotheses to explain clonal outgrowth in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> are: 1) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> cells evade immune attack possibly, because of an absent cell surface GPI-AP that is the target of the immune attack; 2) The PIG-A mutation confers an intrinsic resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> that becomes more conspicuous when the marrow is under immune attack; and 3) A second mutation occurs in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone to give it an intrinsic survival advantage </plain></SENT>
<SENT sid="7" pm="."><plain>These hypotheses may not be mutually exclusive, since data in support of <z:hpo ids='HP_0000001'>all</z:hpo> three models have been generated </plain></SENT>
</text></document>